MedPath

Study for the efficacy evaluation of acupuncture and moxibustion in the treatment of chronic urticaria

Not Applicable
Conditions
chronic urticaria
Registration Number
ITMCTR1900002291
Lead Sponsor
Chengdu University of TCM
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. those who meet the diagnostic criteria of chronic spontaneous urticaria in EAACI/GA2LEN/EDF/WAO urticaria diagnostic guidelines (2017) and China urticaria diagnostic guidelines (2014);
2. aged 18 and 70 years;
3. sign the informed consent form and participate in this study voluntarily. Note: patients who meet the above five criteria at the same time can be included in this study.

Exclusion Criteria

1. patients with unclear consciousness and inability to express subjective discomfort symptoms and mental patients;
2. progressive malignant tumor or other serious wasting disease, easy to be infected and bleeding;
3. patients with cardiovascular, liver, kidney, digestive, hematopoietic and other serious primary diseases;
4. pregnant and lactating women.
5. Used antihistamines within 2 weeks before the study, and steroids and immunosuppressive drugs within 1 month;
6. participating in other ongoing clinical studies.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
urticaria activity score;
Secondary Outcome Measures
NameTimeMethod
Visual Analogue Scale;Dermatology Life Quality Index;Hamilton Depression Scale;Pittsburgh Sleep Quality Index;
© Copyright 2025. All Rights Reserved by MedPath